Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
J Urol. 2022 May;207(5):1029-1037. doi: 10.1097/JU.0000000000002370. Epub 2022 Mar 3.
We aimed to compare patient-reported mental health outcomes for men undergoing treatment for localized prostate cancer longitudinally over 5 years.
We conducted a prospective population-based analysis using the Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study. Patient-reported depressive symptoms (Centers for Epidemiologic Studies Depression [CES-D]) and domains of the Medical Outcomes Study 36-item Short Form survey evaluating emotional well-being and energy/fatigue were assessed through 5 years after treatment with surgery, radiotherapy (with or without androgen deprivation therapy) and active surveillance. Regression models were adjusted for outcome-specific baseline function, demographic and clinicopathological characteristics, and treatment approach.
A total of 2,742 men (median [quartiles] age 64 [59-70]) met inclusion criteria. Baseline depressive symptoms, as measured by the CES-D, were low (median 4, quartiles 1-8) without differences between groups. We found no effect of treatment modality on depressive symptoms (p=0.78), though older age, poorer health, being unmarried and baseline CES-D score were associated with declines in mental health. There was no clinically meaningful association between treatment modality and scores for either emotional well-being (p=0.81) or energy/fatigue (p=0.054).
This prospective, population-based cohort study of men with localized prostate cancer showed no clinically important differences in mental health outcomes including depressive symptoms, emotional well-being, and energy/fatigue according to the treatment received (surgery, radiotherapy, or surveillance). However, we identified a number of characteristics associated with worse mental health outcomes including: older age, poorer health, being unmarried, and baseline CES-D score which may allow for early identification of patients most at risk of these outcomes following treatment.
我们旨在比较 5 年内接受局部前列腺癌治疗的男性患者的心理健康报告结果。
我们使用比较手术和放疗效果分析(CEASAR)研究进行了一项前瞻性基于人群的分析。通过手术、放疗(联合或不联合雄激素剥夺治疗)和主动监测治疗后 5 年内,采用中心流行病学研究抑郁量表(CES-D)和医疗结局研究 36 项简明健康调查评估情绪健康和精力/疲劳的各领域来评估患者报告的抑郁症状。回归模型根据特定结局的基线功能、人口统计学和临床病理特征以及治疗方法进行了调整。
共有 2742 名男性(中位[四分位数]年龄 64 [59-70])符合纳入标准。CES-D 测量的基线抑郁症状较低(中位数 4,四分位数 1-8),各组之间无差异。我们发现治疗方式对抑郁症状没有影响(p=0.78),但年龄较大、健康状况较差、未婚和基线 CES-D 评分与心理健康下降有关。治疗方式与情绪健康(p=0.81)或精力/疲劳(p=0.054)评分之间没有明显的临床相关关系。
这项针对局部前列腺癌男性的前瞻性、基于人群的队列研究表明,根据所接受的治疗(手术、放疗或监测),心理健康结局(包括抑郁症状、情绪健康和精力/疲劳)没有明显的临床差异。然而,我们确定了一些与更差的心理健康结局相关的特征,包括:年龄较大、健康状况较差、未婚和基线 CES-D 评分,这可能有助于在治疗后早期识别最有可能出现这些结局的患者。